{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:18:17Z","timestamp":1707524297416},"reference-count":25,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,8,10]]},"DOI":"10.7759\/cureus.17060","type":"journal-article","created":{"date-parts":[[2021,8,10]],"date-time":"2021-08-10T15:36:52Z","timestamp":1628609812000},"source":"Crossref","is-referenced-by-count":3,"title":["Miller-Fisher Syndrome Presenting as Facial Diplegia With COVID-19 Co-Infection"],"prefix":"10.7759","author":[{"given":"Cuong","family":"Tran","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Blake","family":"Drury","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ho-Wang","family":"Yuen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johanna","family":"Rosenthal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael M","family":"Neeki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1111\/pai.13271","article-title":"The first, holistic immunological model of COVID-19: implications for prevention, diagnosis, and public health measures","volume":"31","author":"Matricardi PM","year":"2020","unstructured":"Matricardi PM, Dal Negro RW, Nisini R. The first, holistic immunological model of COVID-19: implications for prevention, diagnosis, and public health measures. Pediatr Allergy Immunol. 2020, 31:454-70. 10.1111\/pai.13271","journal-title":"Pediatr Allergy Immunol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2020.2065","article-title":"Neuropathogenesis and neurologic manifestations of the coronaviruses in the age of coronavirus disease 2019. A review","volume":"77","author":"Zubair AS","year":"2020","unstructured":"Zubair AS, McAlpine LS, Gardin T, Farhadian S, Kuruvilla DE, Spudich S. Neuropathogenesis and neurologic manifestations of the coronaviruses in the age of coronavirus disease 2019. A review. JAMA Neurol. 2020, 77:1018-27. 10.1001\/jamaneurol.2020.2065","journal-title":"JAMA Neurol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2020.117085","article-title":"Neurological complications of coronavirus infection; a comparative review and lessons learned during the COVID-19 pandemic","volume":"417","author":"Sharifian-Dorche M","year":"2020","unstructured":"Sharifian-Dorche M, Huot P, Osherov M, et al.. Neurological complications of coronavirus infection; a comparative review and lessons learned during the COVID-19 pandemic. J Neurol Sci. 2020, 417:117085. 10.1016\/j.jns.2020.117085","journal-title":"J Neurol Sci"},{"key":"ref4","article-title":"Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus","volume":"426","author":"Li W","year":"2003","unstructured":"Li W, Moore MJ, Vasilieva N, et al.. Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus. Nature. 2003, 426:450-4.","journal-title":"Nature"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1002\/path.1570","article-title":"Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis","volume":"203","author":"Hamming I","year":"2004","unstructured":"Hamming I, Timens W, Bulthuis ML, Lely AT, Navis G, van Goor H. Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis. J Pathol. 2004, 203:631-7. 10.1002\/path.1570","journal-title":"J Pathol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1152\/ajpregu.00292.2006","article-title":"Differential expression of neuronal ACE2 in transgenic mice with overexpression of the brain renin-angiotensin system","volume":"292","author":"Doobay MF","year":"2007","unstructured":"Doobay MF, Talman LS, Obr TD, Tian X, Davisson RL, Lazartigues E. Differential expression of neuronal ACE2 in transgenic mice with overexpression of the brain renin-angiotensin system. Am J Physiol Regul Integr Comp Physiol. 2007, 292:R373-81. 10.1152\/ajpregu.00292.2006","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1111\/ene.14277","article-title":"Does SARS-Cov-2 invade the brain? Translational lessons from animal models","volume":"27","author":"Natoli S","year":"2020","unstructured":"Natoli S, Oliveira V, Calabresi P, Maia LF, Pisani A. Does SARS-Cov-2 invade the brain? Translational lessons from animal models. Eur J Neurol. 2020, 27:1764-73. 10.1111\/ene.14277","journal-title":"Eur J Neurol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1007\/s10072-020-04708-8","article-title":"Neuromuscular presentations in patients with COVID-19","volume":"41","author":"Paliwal VK","year":"2020","unstructured":"Paliwal VK, Garg RK, Gupta A, Tejan N. Neuromuscular presentations in patients with COVID-19. Neurol Sci. 2020, 41:3039-56. 10.1007\/s10072-020-04708-8","journal-title":"Neurol Sci"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1080\/00016489.2019.1651134","article-title":"Bilateral facial palsy","volume":"139","author":"Jung J","year":"2019","unstructured":"Jung J, Park DC, Jung SY, Park MJ, Kim SH, Yeo SG. Bilateral facial palsy. Acta Otolaryngol. 2019, 139:934-8. 10.1080\/00016489.2019.1651134","journal-title":"Acta Otolaryngol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jocn.2020.05.016","article-title":"Facial diplegia, a possible atypical variant of Guillain-Barr\u00e9 Syndrome as a rare neurological complication of SARS-CoV-2","volume":"77","author":"Juliao Caama\u00f1o DS","year":"2020","unstructured":"Juliao Caama\u00f1o DS, Alonso Beato R. Facial diplegia, a possible atypical variant of Guillain-Barr\u00e9 Syndrome as a rare neurological complication of SARS-CoV-2. J Clin Neurosci. 2020, 77:230-2. 10.1016\/j.jocn.2020.05.016","journal-title":"J Clin Neurosci"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1097\/PRS.0000000000002599","article-title":"Bilateral facial paralysis: a 13-year experience","volume":"138","author":"Gaudin RA","year":"2016","unstructured":"Gaudin RA, Jowett N, Banks CA, Knox CJ, Hadlock TA. Bilateral facial paralysis: a 13-year experience. Plast Reconstr Surg. 2016, 138:879-87. 10.1097\/PRS.0000000000002599","journal-title":"Plast Reconstr Surg"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1002\/mus.27024","article-title":"COVID-19-associated Guillain-Barr\u00e9 syndrome: the early pandemic experience","volume":"62","author":"Caress JB","year":"2020","unstructured":"Caress JB, Castoro RJ, Simmons Z, Scelsa SN, Lewis RA, Ahlawat A, Narayanaswami P. COVID-19-associated Guillain-Barr\u00e9 syndrome: the early pandemic experience. Muscle Nerve. 2020, 62:485-91. 10.1002\/mus.27024","journal-title":"Muscle Nerve"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1017\/cjn.2020.106","article-title":"Guillain-Barr\u00e9 syndrome with facial diplegia related to SARS-CoV-2 infection","volume":"47","author":"Chan JL","year":"2020","unstructured":"Chan JL, Ebadi H, Sarna JR. Guillain-Barr\u00e9 syndrome with facial diplegia related to SARS-CoV-2 infection. Can J Neurol Sci. 2020, 47:852-4. 10.1017\/cjn.2020.106","journal-title":"Can J Neurol Sci"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc2009191","article-title":"Guillain-Barr\u00e9 syndrome associated with SARS-CoV-2","volume":"382","author":"Toscano G","year":"2020","unstructured":"Toscano G, Palmerini F, Ravaglia S, et al.. Guillain-Barr\u00e9 syndrome associated with SARS-CoV-2. N Engl J Med. 2020, 382:2574-6. 10.1056\/NEJMc2009191","journal-title":"N Engl J Med"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.3174\/ajnr.A6609","article-title":"COVID-19-associated Miller Fisher Syndrome: MRI findings","volume":"41","author":"Lantos JE","year":"2020","unstructured":"Lantos JE, Strauss SB, Lin E. COVID-19-associated Miller Fisher Syndrome: MRI findings. AJNR Am J Neuroradiol. 2020, 41:1184-6. 10.3174\/ajnr.A6609","journal-title":"AJNR Am J Neuroradiol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000009619","article-title":"Miller Fisher syndrome and polyneuritis cranialis in COVID-19","volume":"95","author":"Guti\u00e9rrez-Ortiz C","year":"2020","unstructured":"Guti\u00e9rrez-Ortiz C, M\u00e9ndez-Guerrero A, Rodrigo-Rey S, et al.. Miller Fisher syndrome and polyneuritis cranialis in COVID-19. Neurology. 2020, 95:e601-5. 10.1212\/WNL.0000000000009619","journal-title":"Neurology"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1111\/ene.14383","article-title":"Miller-Fisher syndrome after SARS-CoV-2 infection","volume":"27","author":"Reyes-Bueno JA","year":"2020","unstructured":"Reyes-Bueno JA, Garc\u00eda-Trujillo L, Urbaneja P, Ciano-Petersen NL, Postigo-Pozo MJ, Mart\u00ednez-Tom\u00e1s C, Serrano-Castro PJ. Miller-Fisher syndrome after SARS-CoV-2 infection. Eur J Neurol. 2020, 27:1759-61. 10.1111\/ene.14383","journal-title":"Eur J Neurol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2020-236419","article-title":"Miller Fisher syndrome and COVID-19: is there a link?","volume":"13","author":"Ray A","year":"2020","unstructured":"Ray A. Miller Fisher syndrome and COVID-19: is there a link?. BMJ Case Rep. 2020, 13:e236419. 10.1136\/bcr-2020-236419","journal-title":"BMJ Case Rep"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1111\/ene.14473","article-title":"Miller-Fisher syndrome after COVID-19: neurochemical markers as an early sign of nervous system involvement","volume":"27","author":"Senel M","year":"2020","unstructured":"Senel M, Abu-Rumeileh S, Michel D, Garibashvili T, Althaus K, Kassubek J, Otto M. Miller-Fisher syndrome after COVID-19: neurochemical markers as an early sign of nervous system involvement. Eur J Neurol. 2020, 27:2378-80. 10.1111\/ene.14473","journal-title":"Eur J Neurol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1007\/s13365-020-00858-9","article-title":"Miller Fisher syndrome diagnosis and treatment in a patient with SARS-CoV-2","volume":"26","author":"Manganotti P","year":"2020","unstructured":"Manganotti P, Pesavento V, Buoite Stella A, et al.. Miller Fisher syndrome diagnosis and treatment in a patient with SARS-CoV-2. J Neurovirol. 2020, 26:605-6. 10.1007\/s13365-020-00858-9","journal-title":"J Neurovirol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-020-09912-2","article-title":"Miller-Fisher-like syndrome related to SARS-CoV-2 infection (COVID 19)","volume":"267","author":"Fern\u00e1ndez-Dom\u00ednguez J","year":"2020","unstructured":"Fern\u00e1ndez-Dom\u00ednguez J, Ameijide-Sanluis E, Garc\u00eda-Cabo C, Garc\u00eda-Rodr\u00edguez R, Mateos V. Miller-Fisher-like syndrome related to SARS-CoV-2 infection (COVID 19). J Neurol. 2020, 267:2495-6. 10.1007\/s00415-020-09912-2","journal-title":"J Neurol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000009700","article-title":"COVID-19 presenting with ophthalmoparesis from cranial nerve palsy","volume":"95","author":"Dinkin M","year":"2020","unstructured":"Dinkin M, Gao V, Kahan J, et al.. COVID-19 presenting with ophthalmoparesis from cranial nerve palsy. Neurology. 2020, 95:221-3. 10.1212\/WNL.0000000000009700","journal-title":"Neurology"},{"key":"ref23","article-title":"Miller Fisher Syndrome","author":"Rocha Cabrero F","year":"2021","unstructured":"Rocha Cabrero F, Morrison EH. Miller Fisher Syndrome. StatPearls [Internet], Treasure Island (FL); 2021."},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000002558","article-title":"Serum and CSF GQ1b antibodies in isolated ophthalmologic syndromes","volume":"86","author":"Spatola M","year":"2016","unstructured":"Spatola M, Du Pasquier R, Schluep M, Regeniter A. Serum and CSF GQ1b antibodies in isolated ophthalmologic syndromes. Neurology. 2016, 86:1780-4. 10.1212\/WNL.0000000000002558","journal-title":"Neurology"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.8318","article-title":"Significance of Brighton Criteria in the early diagnosis and management of Guillain-Barr\u00e9 syndrome","volume":"12","author":"Ghazanfar H","year":"2020","unstructured":"Ghazanfar H, Qazi R, Ghazanfar A, Iftekhar S. Significance of Brighton Criteria in the early diagnosis and management of Guillain-Barr\u00e9 syndrome. Cureus. 2020, 12:e8318. 10.7759\/cureus.8318","journal-title":"Cureus"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/66940-miller-fisher-syndrome-presenting-as-facial-diplegia-with-covid-19-co-infection","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:29:15Z","timestamp":1707506955000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/66940-miller-fisher-syndrome-presenting-as-facial-diplegia-with-covid-19-co-infection"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,10]]},"references-count":25,"URL":"https:\/\/doi.org\/10.7759\/cureus.17060","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8,10]]}}}